JSAC(SH:600389)2024-04-22 10:39Financial Performance - The company's operating revenue for Q1 2024 was CNY 1,585,034,690.16, representing a year-on-year increase of 17.18%[5]. - Total revenue for Q1 2024 reached ¥1,585,034,690.16, an increase of 17.1% compared to ¥1,352,672,296.69 in Q1 2023[17]. - Operating profit for Q1 2024 was ¥108,036,941.63, down 29.4% from ¥153,025,794.85 in Q1 2023[18]. - Net profit for Q1 2024 was ¥84,985,087.54, a decrease of 31.1% compared to ¥123,622,745.10 in Q1 2023[18]. - Total comprehensive income for Q1 2024 was approximately ¥85.10 million, a significant decrease from ¥123.73 million in Q1 2023[19]. Profitability Metrics - The net profit attributable to shareholders decreased by 33.49% to CNY 82,236,390.36, primarily due to a decline in gross margin[5][8]. - Basic and diluted earnings per share both fell by 33.49% to CNY 0.1910[5][8]. - Basic and diluted earnings per share for Q1 2024 were ¥0.1910, down from ¥0.2871 in Q1 2023[19]. - The weighted average return on equity decreased by 1.3978 percentage points to 2.2622%[6]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at CNY -68,378,030.19, a decrease of 170.63% compared to the previous year, attributed to reduced sales collections[5][8]. - Net cash flow from operating activities was -¥68.38 million, down from ¥96.81 million in the same period last year[22]. - Cash and cash equivalents increased to ¥797,674.16 in Q1 2024 from ¥241,592.10 in Q1 2023[13]. - Cash and cash equivalents at the end of Q1 2024 totaled ¥2.18 billion, a decrease from ¥1.95 billion at the end of Q1 2023[23]. - Cash outflow from investing activities was ¥171.73 million, compared to ¥72.70 million in Q1 2023, indicating increased investment expenditures[22]. - Cash inflow from financing activities was ¥50 million, with net cash flow from financing activities improving to ¥23.88 million from -¥5.75 million in Q1 2023[23]. Assets and Liabilities - Total assets at the end of Q1 2024 were CNY 6,622,931,500.49, a decrease of 0.79% from the end of the previous year[6]. - Total assets as of Q1 2024 amounted to ¥6,622,931,500.49, slightly down from ¥6,675,368,502.79 in Q1 2023[14]. - Total liabilities decreased to ¥2,823,664,905.94 in Q1 2024 from ¥2,976,278,584.36 in Q1 2023[14]. - The equity attributable to shareholders increased by 2.71% to CNY 3,688,172,994.61 compared to the end of the previous year[6]. - The total equity attributable to shareholders increased to ¥3,688,172,994.61 in Q1 2024 from ¥3,590,745,015.68 in Q1 2023[15]. Operational Highlights - The increase in operating revenue was mainly driven by a rise in sales volume of certain pesticide products during the reporting period[8]. - The company had a total of 25,302 common shareholders at the end of the reporting period[10]. - Research and development expenses rose to ¥49,970,406.04 in Q1 2024, up from ¥42,249,446.03 in Q1 2023[18]. - The company plans to continue focusing on market expansion and new product development in the upcoming quarters[16]. - The company reported a decrease in inventory to ¥761,407,625.30 in Q1 2024 from ¥816,919,480.43 in Q1 2023[13]. Non-Recurring Items - Non-recurring gains and losses amounted to CNY 2,345,732.21, with government subsidies contributing CNY 2,989,213.40[7]. - The company received ¥14.07 million in tax refunds during Q1 2024, down from ¥19.62 million in Q1 2023[21]. - The company reported an increase in cash received from other operating activities to ¥61.63 million, compared to ¥11.05 million in the previous year[22]. - The company did not report any net profit from subsidiaries prior to consolidation in the current or previous periods[19].